International Journal of Scientific and Research Publications

IJSRP, Volume 3, Issue 9, September 2013 Edition [ISSN 2250-3153]


Safety and Efficacy of Tiotropium Bromide in Copd Patients
      Dr.Sridevi K , Dr.Mohana Rao V, Dr.Vijaya .N, Dr.G.Manoj Someswar
Abstract: Chronic obstructive pulmonary diseases (COPD) are a potentially fatal, slowly progressive respiratory disease. In contrast to Asthma, COPD is characterized by air flow obstruction that is not fully reversible. The signs and symptoms are chronic cough, excessive mucus production, wheezing and shortness of breath after mild exertion. In the USA, COPD affects more than 15 million people, with the majority of the patients being over the age of 50 years and current or past smokers. According to the World Health Organization (WHO) about 600 million people suffer from COPD although many are undiagnosed.

Reference this Research Paper (copy & paste below code):

Dr.Sridevi K , Dr.Mohana Rao V, Dr.Vijaya .N, Dr.G.Manoj Someswar (2018); Safety and Efficacy of Tiotropium Bromide in Copd Patients; Int J Sci Res Publ 3(9) (ISSN: 2250-3153). http://www.ijsrp.org/research-paper-0913.php?rp=P211702
©️ Copyright 2011-2022 IJSRP - All rights reserved. Use of this web site signifies your agreement to the terms and conditions.